Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

The Effect of Breastfeedıng and Kangaroo Care Applıed Before Heel Blood Collectıon on Newborn Paın and Comfort

5 mai 2026 mis à jour par: BÜŞRA SERTAKAN BAŞPINAR, Cumhuriyet University

The Effect of Breastfeedıng and Kangaroo Care Applıed Before Heel Blood Collectıon on Newborn Paın and Comfort: A Randomızed Controlled Study

This research will be conducted using a randomized controlled, double-blind experimental design to determine the effects of breastfeeding and kangaroo care on the pain and comfort of newborn babies before heel prick blood sampling. The study group will consist of newborn babies, and one of the observers administering the pain and comfort scores will be independent of the research participants, with the observer evaluating the babies without knowing which group they belong to.

Study Hypotheses H0a = Breastfeeding before heel prick test in newborns does not affect the baby's pain.

H1a = Breastfeeding before heel prick test in newborns reduces the baby's pain. H0b = Kangaroo care before heel prick test in newborns does not affect the baby's pain.

H1b = Kangaroo care before heel prick test in newborns reduces the baby's pain. H0c = Breastfeeding before heel prick test in newborns does not affect the baby's comfort level.

H1c = Breastfeeding before heel prick test in newborns increases the baby's comfort level.

H0d = Kangaroo care before heel prick test in newborns does not affect the baby's comfort level.

H1d = Kangaroo care before heel prick test in newborns increases the baby's comfort level.

The research is planned to be conducted at the Obstetrics and Gynecology Department of Sivas Cumhuriyet University Women's and Children's Hospital in Sivas city center between February 1, 2025 and March 1, 2026.

The study population will consist of newborns born by cesarean section and admitted to the Obstetrics and Gynecology ward of Sivas Cumhuriyet University Health Services Application and Research Hospital. The study sample will comprise newborns born by cesarean section and admitted to the Obstetrics and Gynecology ward of Sivas Cumhuriyet University Health Services Application and Research Hospital who meet the study criteria. The study (breastfeeding group, kangaroo care group) and control groups will consist of a total of 120 newborns.

The following instruments will be used to collect research data: Newborn and Parent Demographic Information Form, Neonatal Infant Pain Scale (NIPS), Neonatal Comfort Behavior Scale, informed consent form, and Blinded Evaluator NIPS form. The study will also utilize a pulse oximeter, a camera, and a stopwatch.

Aperçu de l'étude

Statut

Complété

Les conditions

Intervention / Traitement

Description détaillée

Heel prick blood sampling is one of the invasive procedures frequently performed in divorces. Ensuring the proper continuation and survival of fractures that occur during this procedure is of great importance. Nurses have responsibilities regarding the identification of cooling and comfort components of equipment, the operation of appropriate interventions using this equipment, and the maintenance of basic comfort enhancement. While there are limited industrial studies on the combined use of breastfeeding and kangaroo care for pain relief, no studies have been found that evaluate pain and temperature together. There is a need for current reports on monitoring, prevention, and treatment related to pain control in preterm and term newborns monitored both in and out of hospitals. In this context, the aim of our study is to determine the duration of pain and temperature associated with breastfeeding and kangaroo care applied before heel prick blood sampling in newborns.

Type d'étude

Interventionnel

Inscription (Réel)

120

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

  • Turquie (Türkiye)
    • Merkez
      • Sivas, Merkez, Turquie (Türkiye), 58030
        • Sivas Cumhuriyet Üniversitesi Sağlık Hizmetleri Uygulama ve Araştırma Hastanesinde Kadın Hastalıkları Obs-tetri servisi

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant

Accepte les volontaires sains

Oui

La description

Inclusion Criteria:

  • Parental consent must be obtained in accordance with the participant information and consent form
  • The baby must be term, between 37-42 weeks gestation
  • Birth weight must be 2500 grams or more
  • The mother must be present with the baby
  • The baby must be healthy (no physical, metabolic, or genetic diseases, no surgical procedures have been performed)
  • There must be no condition that prevents pain assessment (neuromotor developmental delay, etc.)
  • The baby must not have undergone any invasive procedures other than routine interventions
  • The baby must have been born by cesarean section
  • The mother must speak and understand Turkish fluently

Exclusion Criteria:

  • Pre-procedure NIPS score of 3 or higher
  • Lack of parental consent based on participant information and consent form
  • Newborn born before 37 weeks of gestation
  • Birth weight under 2500 grams
  • Unstable general condition
  • Vaginal delivery
  • Invasive procedures performed on the baby other than routine procedures
  • Failure to obtain heel prick blood on the first attempt
  • Mother not speaking Turkish

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Non randomisé
  • Modèle interventionnel: Affectation factorielle
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: This is the group where the baby is breastfed before the heel prick blood test. In this group, the e
Breastfeeding Group (Group 1) Each baby in the group will be breastfed for 15-30 minutes before the heel prick blood test. Physiological parameters, NIPS, and comfort behavior will be evaluated before, during and after the procedure. In addition, the duration of the newborn's crying will be recorded with a stopwatch during the heel prick blood test.
Autre: breastfeeding
Before the heel prick blood test, a newborn information form and a parent identification form will be completed. Parents will be given information about breastfeeding, and physiological parameters, NIPS (Neural Network Indicators), and comfort behavior will be evaluated before the procedure. Each baby in the group will be breastfed for 15-30 minutes before the heel prick blood test. Physiological parameters, NIPS, and comfort behavior will be evaluated during and after the procedure. In addition, the duration of the newborn's crying will be recorded with a stopwatch during the heel prick blood test. The newborn will be recorded with a camera during the procedure for evaluation by the blind evaluator.
Expérimental: This group receives skin-to-skin contact (kangaroo care) before the heel prick blood test on the bab
Kangaroo Care Group (Group 2) Each baby in the group will be given 30 minutes of kangaroo care before heel prick blood is taken. Physiological parameters, NIPS (Neural Network Imaging System) scores, and comfort behavior will be evaluated before, during, and after the procedure.
Autre: Kangaroo Care
Before the procedure, a newborn information form and a parent identification form will be completed. Parents will be given information about kangaroo care, and physiological parameters, NIPS (Neural Network Indicators), and comfort behavior will be evaluated before the procedure. Each baby in the group will be provided with kangaroo care for 30 minutes before the heel prick blood sample is taken. Physiological parameters, NIPS, and comfort behavior will be evaluated during and after the procedure. In addition, the duration of the newborn's crying will be recorded with a stopwatch during the procedure. The newborn will be recorded with a camera during the procedure for evaluation by the blind evaluator.
Expérimental: This is the group that receives standard care.
Control Group (Group 3) Physiological parameters, NIPS (Neuroprocedure Testing System), and comfort behavior will be evaluated before, during, and after the procedure.
Autre: Standard Care (in control arm)
No intervention will be performed. Routine hospital procedure will be applied.Physiological parameters, NIPS (Neuro-Visual Imaging System), and comfort behavior will be evaluated before, during, and after the procedure. Additionally, the newborn's crying duration will be recorded using a stopwatch during the procedure. The newborn will also be recorded on camera during the procedure for evaluation by a blind evaluator.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Determining the appropriate interval for breastfeeding and kangaroo care in newborns before heel prick blood sampling, as well as assessing pain and temperature.
Délai: about a year
Newborn Infant Pain Scale Assessment Form: The NIPS Form is used to assess pain and consists of six behavioral responses: facial expression, emission pattern, arms, fullness, and volume. Crying performance is given three points (0-1-2), while other behaviors are given only two points (0-1). The total score is calculated based on the Neonatal Pain Scale, with a maximum score of 7 and a minimum score of 0. A NIPS score between 0-2 indicates no pain and requires no intervention. A pain score between 3-4 indicates moderate acoustic pain, and complementary and alternative interventions are applied. A pain score above four suggests complementary and alternative Neonatal Comfort Behavior Scale (NICS): Each item on the scale is scored from 1 to 5. The overall score is used for evaluation. The lowest possible score on the Newborn Comfort Behavior Scale is 6, and the highest is 30. A total score between 9-13 indicates that the baby is comfortable, while a score between 14-30 indicates that th
about a year

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Cumhuriyet University

Collaborateurs

Cumhuriyet University Hospital

Les enquêteurs

  • Directeur d'études: FERDAĞ YILDIRIM, SİVAS CUMHURİYET ÜNİVERSİTESİ SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU
  • Directeur d'études: EMİNE ALTUN YILMAZ, SİVAS CUMHURİYET ÜNİVERSİTESİ SAĞLIK BİLİMLERİ FAKÜLTESİ HEMŞİRELİK BÖLÜMÜ

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

20 février 2025

Achèvement primaire (Réel)

1 janvier 2026

Achèvement de l'étude (Réel)

1 janvier 2026

Dates d'inscription aux études

Première soumission

1 avril 2026

Première soumission répondant aux critères de contrôle qualité

5 mai 2026

Première publication (Réel)

12 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

12 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

5 mai 2026

Dernière vérification

1 février 2025

Plus d'information

Termes liés à cette étude

Mots clés

Termes MeSH pertinents supplémentaires

Autres numéros d'identification d'étude

  • CU-SBF-BSB-01

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner